FNY Investment Advisers’s VIVEVE MED INC VIVE Stock Holding History

FNY Investment Advisers’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,614	Closed	-$71K	–	1135
2019 Q3	$71K	Buy	+1,614	New	+$291K	0.02%	360

Other funds holding VIVE

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FNY Investment Advisers's VIVE Position: Q4 2019 in Review

FNY Investment Advisers sold out of VIVEVE MED INC (VIVE) in Q4 2019, closing a stake of 1,614 shares — an estimated $71K sold.

FNY Investment Advisers first reported a position in VIVE in Q3 2019 and held it in 1 quarter. The position peaked at $71K in Q3 2019. 13 funds tracked by Wall St. Rank hold VIVE as of Q4 2019.

FNY Investment Advisers reported no remaining VIVEVE MED INC position as of Q4 2019 after selling out during the quarter.
FNY Investment Advisers sold 1,614 VIVEVE MED INC shares in Q4 2019, an estimated $71K.
FNY Investment Advisers first reported a position in VIVEVE MED INC in Q3 2019 and held it in 1 quarter.
FNY Investment Advisers's VIVEVE MED INC position peaked at $71K in Q3 2019.
13 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q4 2019.

Based on FNY Investment Advisers's 13F filing for Q4 2019, filed 10 Jan 2020.